Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Melbrosin Group is an Austrian healthcare company specializing in the development and distribution of natural revitalizing supplements and nutraceuticals. The company is best known for its "Melbrosin" product line, which utilizes flower pollen and royal jelly to alleviate symptoms associated with menopause and to support overall vitality. Founded in Vienna, the group focuses on high-quality natural ingredients and has established a presence in several international markets. Their portfolio includes various formulations targeting hormonal balance, immune support, and physical well-being. Additionally, the group operates a specialized medical center in Vienna dedicated to holistic health and vital substance therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Melbrosin Group.